Taiji Matsuda
Kindai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Taiji Matsuda.
Diseases of The Colon & Rectum | 1994
Eiji Morikawa; Masayuki Yasutomi; Katsuhisa Shindou; Taiji Matsuda; Nobuhira Mori; Jin-ichi Hida; Ryuichi Kubo; Masanori Kitaoka; Masato Nakamura; Kiyonari Fujimoto; Haruhiko Inufusa; Masaki Hatta; Gentaro Izumoto
PURPOSE: The aim of this study was to clarify the distribution of lymph node metastasis in colorectal cancer. We also examined the relationship between the primary tumor (T) and the regional node (N) categories of the TNM (primary tumor, regional nodes, metastasis) classification. METHOD: Lymph nodes of surgical specimens in 311 consecutive patients with colorectal cancer were studied using the modified clearing method. RESULTS: Lymph node metastasis was seen in 59.2 percent of the total cases. The upward metastasis rate was 30.7 percent. In the longitudinal spread, most of the lymph node metastasis was seen within 10 cm. On the oral side in rectal cancer, there was no metastasis beyond 4 cm. The lateral metastasis rate in rectal cancer was 8.8 percent and in the lower rectum, the rate of cancer within 6 cm from the anal verge or beyond pT3 was much higher. CONCLUSION: In the TNM classification, there was no significant difference between colon and rectal cancer except pT1 with rectal cancer. In the lower rectal cancer within 6 cm from the anal verge or beyond pT3, there is a high risk of lateral metastasis, and lateral lymph node dissection or radiation therapy should be performed.
Surgery Today | 1993
Masahiro Watatani; Masaru Ooshima; Tomio Wada; Hideharu Terashita; Taiji Matsuda; Katsuhisa Shindo; Masayuki Yasutomi
We report herein three cases of patients with adrenal metastases from colorectal carcinoma. Recurrent disease was suspected following markedly elevated levels of serum carcinoembryonic antigen (CEA), and adrenal metastases were confirmed by computed tomography (CT) scanning in all three patients. The adrenal metastasis was solitary in one patient and this patient is still alive and free from disease 1 year after undergoing complete removal of the adrenal metastasis. On the other hand, metastatic disease was not limited to the adrenal gland in the other two patients and both died of recurrent disease, 33 months and 4 months after undergoing removal of the adrenal metastases, respectively. Thus, although the prognosis of adrenal metastasis from colorectal cancer is usually poor, we believe that patients with a solitary adrenal metastasis will benefit from complete removal of the metastasis.
Cancer | 1994
Jin-ichi Hida; Taiji Matsuda; Masanori Kitaoka; Norikazu Machidera; Ryuichi Kubo; Masayuki Yasutomi
Background. Basement membrane (BM) is a specialized extracellular matrix component that plays a key role in tumor invasion and metastasis.
Surgery Today | 1988
Zenji Iwasa; Nobuki Matsunami; Yuji Saeki; Kazuyoshi Kurooka; Munehisa Yamato; Kiyotaka Okuno; Noriyuki Sagara; Taiji Matsuda; Masayuki Yasutomi
Preoperative intra-arterial infusion neo-adjuvant chemotherapy, in combination with local vein blocking, was administered to thirtyone patients with locally advanced stage III breast cancer. The anti-cancer drugs and dosages used were 500 mg of 5-Fluorouracil (5FU), which was infused daily for 7–14 days, and 20 mg of Adriamycin (ADM), which was administered as a bolus dose twice into the subclavian and internal mammary arteries. The response rate of this method on the primary tumor was 48.4 per cent, and, histologically it was found to be as high as 90.3 per cent. The response rate of the clinical effects on the regional lymph nodes was 50.0 per cent, however, histologically, it was found to be lower than that of the primary tumor. In the long-term follow up study the 5-year survival rate was 72.2 per cent. Thus, this method seems to be effective as a combined modality in cases of locally advanced stage III breast cancer.
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1985
Masayuki Yasutomi; Taiji Matsuda; Masaaki Ogawa; Jiro Maruyama; Ikuhiro Sakata; Kazuyoshi Kurooka; Yasuhiro Katsura; Zenji Iwasa
SDラットの回腸を結腸間に有茎移植術を行ったのち, 1, 2-dimethylhydrazine (DMH) 10mg/kg×16週を投与し, 大腸発癌の促進因子を解明しようとした.手術の影響を除外し, 回腸上皮の結腸化の可能性を検討するために, DMH投与開始時期を術後2週と16週に分けた. 術後2週の群, 16週の群ともにそれぞれ9.5%, 6.5%の頻度で結腸間に移植した回腸に発癌した. しかし対照群および移植群でも正常回腸には癌は認められなかった. このことから, 本来回腸にはDMH発癌に抵抗性であるが, 結腸間移植により発癌すること, 術後早期投与群では手術による促進作用, 晩期投与群では回腸粘膜の変化による発癌促進があることが推察された.
Japanese Journal of Clinical Oncology | 1983
Taiji Matsuda; Masaaki Ogawa; Jiro Maruyama; Yasuhiro Katsura; Masayuki Yasutomi
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1992
Shinji Ushida; Kazuyoshi Kurooka; Sadao Funai; Hiromi Yamada; Yoshinori Fujii; Yukio Imanishi; Taiji Matsuda; Katsuhisa Shinodo; Masayuki Yasutomi
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1991
Taiji Matsuda; Yoshitaka Akabane; Toshiyuki Adachi; Jin-ichi Hida; Kohei Mori; Masayuki Yasutomi
Nippon Daicho Komonbyo Gakkai Zasshi | 1990
Ryuichi Kubo; Taiji Matsuda; Jin-ichi Hida; Yoshitaka Akabane; Toshiyuki Adachi; Katsuhisa Shindo; Masayuki Yasutomi
Archive | 1986
Masayuki Yasutomi; Taiji Matsuda; Masaaki Ogawa; Zenji Iwasa; Jiro Maruyama; Ikuhiro Sakata; Kazuyoshi Kurooka; Yasuhiro Katsura